Axon Enterprise, Inc $AXON Shares Purchased by Fjarde AP Fonden Fourth Swedish National Pension Fund

Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 60.5% during the first quarter, HoldingsChannel.com reports. The firm owned 19,080 shares of the biotechnology company’s stock after acquiring an additional 7,190 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Axon Enterprise were worth $8,103,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. Creative Financial Designs Inc. ADV purchased a new stake in shares of Axon Enterprise during the 4th quarter valued at $28,000. Sound Income Strategies LLC raised its position in shares of Axon Enterprise by 550.0% in the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after buying an additional 44 shares during the period. Camelot Portfolios LLC purchased a new position in shares of Axon Enterprise in the 4th quarter worth $30,000. AlphaCentric Advisors LLC acquired a new position in Axon Enterprise in the fourth quarter valued at $34,000. Finally, Lodestone Wealth Management LLC acquired a new position in Axon Enterprise in the fourth quarter valued at $35,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insiders Place Their Bets

In related news, President Joshua Isner sold 13,000 shares of the firm’s stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $488.45, for a total transaction of $6,349,850.00. Following the sale, the president directly owned 169,125 shares in the company, valued at approximately $82,609,106.25. This trade represents a 7.14% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, June 29th. The stock was sold at an average price of $500.00, for a total value of $5,000,000.00. Following the transaction, the chief executive officer directly owned 3,050,997 shares in the company, valued at $1,525,498,500. This trade represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 48,989 shares of company stock valued at $24,090,083. Company insiders own 4.20% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $597.04 on Monday. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $885.91. The company has a market cap of $48.12 billion, a P/E ratio of 239.78, a P/E/G ratio of 12.18 and a beta of 1.38. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.49. The stock has a fifty day moving average price of $437.68 and a 200 day moving average price of $481.91.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The company had revenue of $807.35 million for the quarter, compared to analysts’ expectations of $778.90 million. During the same quarter in the previous year, the firm posted $1.47 earnings per share. The firm’s quarterly revenue was up 33.7% on a year-over-year basis. Research analysts anticipate that Axon Enterprise, Inc will post 1.63 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. Weiss Ratings upgraded Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 8th. Citizens Jmp reaffirmed a “market outperform” rating and issued a $700.00 price objective on shares of Axon Enterprise in a research note on Thursday, June 25th. The Goldman Sachs Group set a $535.00 target price on Axon Enterprise in a report on Thursday, May 7th. JPMorgan Chase & Co. increased their target price on shares of Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Finally, Morgan Stanley set a $600.00 price target on shares of Axon Enterprise in a report on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $712.75.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.